Ochratoxin A levels in blood serum of Czech women in the first trimester of pregnancy and its correspondence with dietary intake of the mycotoxin contaminant

References

• Anderson GD. (2005). Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44:989–1008
   PubMed Web of Science ®Google Scholar
• Appelgreen LE, Arora RG. (1983a). Distribution studies of 14C-labelled ochratoxin A in pregnant mice. Food Chem Toxicol 21:563–8
   PubMedGoogle Scholar
• Appelgreen LE, Arora RG. (1983b). Distribution studies of 14C-labelled aflatoxin B1 and ochratoxin A in pregnant mice. Vet Res Commun 7:141–4
   PubMedGoogle Scholar
• Biasucci G, Calabrese G, Di Giuseppe R, et al. (2010). The presence of ochratoxin A in cord serum and in human milk and its correspondence with maternal dietary habits. Eur J Nutr 50:211–18
   PubMedGoogle Scholar
• Boon PE, Bonthuis M, van der Voet H, van Klaveren JD. (2011). Comparison of different exposure assessment methods to estimate the long-term dietary exposure to dioxins and ochratoxin A. Food Chem Toxicol 49:1979–88
   PubMed Web of Science ®Google Scholar
• Boorman G, ed. (1989). Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). NIH Publication No. 89-2813, NTP Technical report on the toxicology and carcinogenesis studies of ochratoxin A. Research Triangle Park, NC: Department of Health and Human Services, National Institute of Health. 358:1–142
   Google Scholar
• Breitholtz A, Olsen M, Dahlbäck Å, Hult K. (1991). Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit Contam 8:183–92
   PubMed Web of Science ®Google Scholar
• Chu FS. (1971). Interaction of ochratoxin A with bovine serum albumine. Arch Biochem Biophys 147:359–66
   PubMed Web of Science ®Google Scholar
• Chu FS. (1974). A comparative study of the interaction of ochratoxins with bovine serum albumine. Biochem Pharmacol 23:1105–7
   PubMed Web of Science ®Google Scholar
• Coronel MB, Marin S, Cano-Sancho G, et al. (2012). Exposure assessment to ochratoxin A in Catalonia (Spain) based on the consumption of cereals, nuts, coffee, wine, and beer. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 29:979–93
   PubMedGoogle Scholar
• Creppy EE, Castegnaro M, Grosse Y, et al. (1993). Etude de ĺochratoxicose humaine dans trios regions de France: Alsace, Aquitaine et region Rhône-Alpes. In: Creppy EE, Castegnaro M, Dirheimer G, eds. Human ochratoxicosis and its pathologies. Proceeding of the International Symposium: Human ochratoxicosis and associated pathologies in Africa and developing countries 1993. Bordeaux, France: Colloque INSERM/John Libbey Eurotext Ltd., 147–58
   Google Scholar
• Duarte SC, Pena A, Lino CM. (2011). Human ochratoxin a biomarkers–from exposure to effect. Crit Rev Toxicol 41:187–212
   PubMed Web of Science ®Google Scholar
• EFSA. (2006). Opinion of the scientific panel on contaminants in the food chain on request from the commission related to ochratoxin A in food. EFSA J 365:1–56
   Google Scholar
• Gilbert J, Brereton P, MacDonald S. (2001). Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit Contam 18:1088–93
   PubMed Web of Science ®Google Scholar
• Haighton LA, Lynch BS, Magnuson BA, Nestmann ER. (2012). A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model. Crit Rev Toxicol 42:147–68
   PubMed Web of Science ®Google Scholar
• Hartwig IR, Pincus MK, Diemert A, et al. (2013). Sex-specific effect of first-trimester maternal progesterone on birthweight. Hum Reprod 28:77–86
   PubMed Web of Science ®Google Scholar
• IARC. (1993). Monographs on the evaluation of carcinogenic risks to humans: some naturally occuring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, France: IARC, 56:489–524
   Google Scholar
• Jennings-Gee JE, Tozlovanu M, Manderville R, et al. (2010). Ochratoxin A: in utero exposure in mice induces adducts in testicular DNA. Toxins 2:1428–44
   PubMedGoogle Scholar
• JECFA. (2002). Evaluation of certain mycotoxins in food: ochratoxin A. WHO Technical Report Series. Geneva, Switzerland: WHO
   Google Scholar
• JECFA. (2008). Ochratoxin A. In safety evaluation of certain food additives and contaminants. WHO Food Additives. Geneva, Switzerland: WHO
   Google Scholar
• Katagiri R, Kurome M, Teshima Y, et al. (2007). Prevention of ochratoxin A-induced neural tube defects by folic acid in the genetic polydactyly/arhinencephaly mouse. Pdn/Pdn Congenital Anomalies 47:90–6
   PubMedGoogle Scholar
• Klaassen CD. (1986). Distribution, excretion and absorption of toxicants. In: Klassen CD, Amdur MO, Doull J, eds. Casarett and Doulĺs toxicology. The basic science of poisons. 3rd ed. New York: Macmillan, 33–63
   Google Scholar
• Klapec T, Šarkanj B, Banjari I, Strelec I. (2012). Urinary ochratoxin A and ochratoxin alpha in pregnant women. Food Chem Tox 50:4487–92
   PubMed Web of Science ®Google Scholar
• Kuiper-Goodman T, Hilts C, Billiard SM, et al. (2010). Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 27:212–40
   PubMed Web of Science ®Google Scholar
• Loebstein R, Koren G. (2002). Clinical relevance of therapeutic drug monitoring during pregnancy. Ther Drug Monit 24:15–22
   PubMed Web of Science ®Google Scholar
• Malir F, Roubal T, Brndiar M, et al. (2001). Ochratoxin A in the Czech Republic. J Toxico-Toxin Rev 20:261–74
   Web of Science ®Google Scholar
• Malir F, Roubal T, Brndiar M, et al. (2008). The monitoring mycotoxins and their potential impact on human health: ochratoxin A (in Czech). Proceedings of 4. Seminary with International Participation. Mycotoxins 2008, Prague: Crop Research Institute, 27–36
   Google Scholar
• Malir F, Ostry V, Pfohl-Leszkowicz A, Roubal T. (2012). Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries. Biomarkers 17:577–89
   PubMed Web of Science ®Google Scholar
• Malir F, Ostry V, Novotna E. (2013). Toxicity of the mycotoxin ochratoxin A (OTA) in the light of recent data. Toxin Rev 32:19–33
   Web of Science ®Google Scholar
• Mally A. (2012). Ochratoxin A and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A. Tox Sci 127:315–30
   PubMed Web of Science ®Google Scholar
• Mally A, Dekant W. (2009). Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents. Mol Nutr Food Res 53:467–8
   PubMed Web of Science ®Google Scholar
• Märtlbauer E, Usleber E, Dietrich R, Schneider E. (2009). Ochratoxin A in human blood serum–retrospective long-term data. Mycotox Res 25:175–86
   PubMedGoogle Scholar
• Mayura K, Reddy RV, Hayes AW, Berndt WO. (1982). Embryocidal, fetotoxic and teratogenic effects of ochratoxin A in rats. Toxicology 25:175–85
   PubMedGoogle Scholar
• Medina A, Mateo EM, Roig RJ, et al. (2010). Ochratoxin A levels in the plasma of healthy blood donors from Valencia and estimation of exposure degree: comparison with previous national Spanish data. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 27:1273–84
   PubMedGoogle Scholar
• Miraglia M, Brera C, Colatosti M. (1996). Application of biomarkers to assessment of risk to human health from exposure to mycotoxins. Microchem J 54:472–7
   Web of Science ®Google Scholar
• Miraglia M, Brera C. (2002). Assessment of dietary intake of ochratoxin A by the population of EU Member States. Directorate–General Health and Consumer Protect Task 3.2.7, 1–153
   Google Scholar
• Nielsen JKS, Vikström AC, Turner P, Knudsen LE. (2011). Deoxynivalenol transport across the human placental barrier. Food Chem Toxicol 49:2046–52
   PubMed Web of Science ®Google Scholar
• Ostry V, Skarkova J, Dofkova M, et al. (2012). Occurrence of ochratoxin A in foodstuffs of plant origin and an assessment of dietary exposure in the Czech Republic – preliminary results. 7th Conference of The World Mycotoxin Forum and XIII th IUPAC International Symposium on Mycotoxins and Phycotoxins. Rotterdam, The Netherlands: WMFmeetsIUPAC 2012, 129–30
   Google Scholar
• Partanen HA, El-Nezami HS, Leppanen JM, et al. (2010). Aflatoxin B1 transfer and metabolism in human placenta. Toxicol Sci 113:216–25
   PubMed Web of Science ®Google Scholar
• Patil RD, Dwivedi P, Sharma AK. (2006). Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats. Reprod Toxicol 22:679–87
   PubMed Web of Science ®Google Scholar
• Petkova-Bocharova T, Stoichev II, Chernozemsky IN, et al. (1998a). Formation of DNA adducts in tissues of mice progeny through transplacental contamination and/or lactation after administration of a single dose of ochratoxin A to pregnant mother. Environ Mol Mutagen 32:155–62
   PubMed Web of Science ®Google Scholar
• Petkova-Bocharova T, Pfohl-Leszkowicz A, Hadjiolov D, Spirov K. (1998b). Investigation on the genotoxicity of ochratoxin A by measurement of DNA-adducts in different organs of Syrian hamsters. Rev Med Vet 149:658
   Google Scholar
• Pfohl-Leszkowicz A, Vrabcheva T, Petkova-Bocharova T, et al. (2004). Analysis of ochratoxin a in serum, urine and food consumed by inhabitants from an area with Balkan endemic nephropathy: a one month follow up study. In: Njapau H, Trujillio S, Van Egmond HP, Park DL, eds. Mycotoxins and phycotoxins. Proceeding of the XIth international IUPAC symposium on mycotoxins and phycotoxins 2004. Bethesda, MD: Wageningen: Academic Publishers, 217–24
   Google Scholar
• Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, et al. (2007). New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol Nutr Food Res 51:131–46
   Web of Science ®Google Scholar
• Pfohl-Leszkowicz A, Manderville RA. (2012). An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity. Chem Res Toxicol 25:252–62
   PubMed Web of Science ®Google Scholar
• Porter RS. (2004). The Merck manual's online medical library. 2nd ed. Whitehouse Station: Merck Research Lab, 1–521
   Google Scholar
• Postupolski J, Karlowski K, Kubik P. (2006). Ochratoxin A in maternal and metal blood and in maternal milk. Rocz Panstw Zakl Hig 57:23–30
   PubMedGoogle Scholar
• Rosner H, Rohrmann B, Peiker G. (2000). Ochratoxin A in human serum. Arch Lebensmittelhyg 51:104–7
   Web of Science ®Google Scholar
• Ruprich J, Dofkova M, Rehurkova I, et al. (2006). Individuální spotřeba potravin – národní studie SISP04. CHPR SZU v Praze. Available from: http://www.szu.cz/tema/bezpecnost-potravin/individualni-spotreba-potravin-v-cr [last accessed 10 May 2013]
   Google Scholar
• Scott PM. (2005). Biomarkers of human exposure to ochratoxin A. Food Addit Contam Suppl 1:99–107
   Google Scholar
• Skarkova J, Ostry V, Malir F, Roubal T. (2013). Determination of ochratoxin A in food by high performance liquid chromatography. Anal Lett 46:1495–504
   Web of Science ®Google Scholar
• Thuvander A, Paulsen JE, Axberg K, et al. (2001). Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 39:1145–51
   PubMed Web of Science ®Google Scholar
• Wangikar PB, Dwivedi P, Sinha N. (2004). Teratogenic effects of ochratoxin A in rabbits. World Rabbit Sci 12:159–171
   Google Scholar
• Wangikar PB, Dwivedi P, Sinha N, et al. (2005). Teratogenic effects in rabbits of simultaneous exposure to ochratoxin A and aflatoxin B1 with special reference to microscopic effects. Toxicology 215:37–47
   PubMed Web of Science ®Google Scholar
• Woo ChSJ, Partanen H, Myllynen P, et al. (2012). Fate of the teratogenic and carcinogenic ochratoxin A in human perfused placenta. Toxicol Lett 208:92–9
   PubMed Web of Science ®Google Scholar
• Zimmerli B, Dick R. (1995). Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high, performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J Chromatogr B 666:85–99
   PubMed Web of Science ®Google Scholar
• Zusterzeel PLM, Nelen WLDM, Roelofs HMJ, et al. (2000). Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss. Mol Hum Reprod 6:474–8
   PubMedGoogle Scholar